surgical approach direct lateral (Hardinge Inc)
Structured Review

Surgical Approach Direct Lateral, supplied by Hardinge Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surgical+approach+direct+lateral/pmc10408532-69-8-15?v=Hardinge+Inc
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "The effects of allogeneic and autologous blood transfusion on immune function in patients receiving total hip replacement"
Article Title: The effects of allogeneic and autologous blood transfusion on immune function in patients receiving total hip replacement
Journal: American Journal of Translational Research
doi:
Figure Legend Snippet: Changes of NKCC before and after blood transfusion (mean ± SD). A. The NKCC (E:T = 10:1) of patients of total hip replacement was detected by ELISA. B. The NKCC (E:T = 5:1) of patients of total hip replacement was detected by ELISA. P < 0.01 (**). E: effector cell; T: target cell; NKCC: natural killer cell cytotoxicity.
Techniques Used: Enzyme-linked Immunosorbent Assay
Figure Legend Snippet: CD3+, CD4+ and IgE levels. A. Cellular immune factor CD3+ of patients after total hip replacement was detected by flow cytometry. B. Cellular immune factor CD4+ of patients after total hip replacement was detected by flow cytometry. C. IgE of patients after total hip replacement was detected by flow cytometry. ▲Compared with preoperative level, P < 0.05; P < 0.05 (*), P < 0.01 (**), compared with allo-group. IgE: Immunoglobulin E.
Techniques Used: Flow Cytometry